transblood limited
transblood limited Company Information
Company Number
07493663
Website
-Registered Address
2 ark avenue, borehamwood, hertfordshire, WD6 1GH
Industry
Other human health activities
Specialist medical practice activities
Telephone
-
Next Accounts Due
October 2024
Group Structure
View All
Directors
Jan Majkowski13 Years
Shareholders
jan majkowski 100%
transblood limited Estimated Valuation
Pomanda estimates the enterprise value of TRANSBLOOD LIMITED at £14.6k based on a Turnover of £33.5k and 0.44x industry multiple (adjusted for size and gross margin).
transblood limited Estimated Valuation
Pomanda estimates the enterprise value of TRANSBLOOD LIMITED at £0 based on an EBITDA of £-3.8k and a 3.39x industry multiple (adjusted for size and gross margin).
transblood limited Estimated Valuation
Pomanda estimates the enterprise value of TRANSBLOOD LIMITED at £14.4k based on Net Assets of £5.7k and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Transblood Limited Overview
Transblood Limited is a live company located in hertfordshire, WD6 1GH with a Companies House number of 07493663. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in January 2011, it's largest shareholder is jan majkowski with a 100% stake. Transblood Limited is a established, micro sized company, Pomanda has estimated its turnover at £33.5k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Transblood Limited Health Check
Pomanda's financial health check has awarded Transblood Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
7 Weak
Size
annual sales of £33.5k, make it smaller than the average company (£421.8k)
- Transblood Limited
£421.8k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Transblood Limited
- - Industry AVG
Production
with a gross margin of 27.4%, this company has a higher cost of product (51.4%)
- Transblood Limited
51.4% - Industry AVG
Profitability
an operating margin of -11.4% make it less profitable than the average company (11.2%)
- Transblood Limited
11.2% - Industry AVG
Employees
with 1 employees, this is below the industry average (9)
1 - Transblood Limited
9 - Industry AVG
Pay Structure
on an average salary of £31.1k, the company has an equivalent pay structure (£31.1k)
- Transblood Limited
£31.1k - Industry AVG
Efficiency
resulting in sales per employee of £33.5k, this is less efficient (£78.2k)
- Transblood Limited
£78.2k - Industry AVG
Debtor Days
it gets paid by customers after 108 days, this is later than average (45 days)
- Transblood Limited
45 days - Industry AVG
Creditor Days
its suppliers are paid after 53 days, this is slower than average (31 days)
- Transblood Limited
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Transblood Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Transblood Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 42.5%, this is a higher level of debt than the average (38.1%)
42.5% - Transblood Limited
38.1% - Industry AVG
TRANSBLOOD LIMITED financials
Transblood Limited's latest turnover from January 2023 is estimated at £33.5 thousand and the company has net assets of £5.7 thousand. According to their latest financial statements, Transblood Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | ||||||||||||
| Gross Profit | ||||||||||||
| Admin Expenses | ||||||||||||
| Operating Profit | ||||||||||||
| Interest Payable | ||||||||||||
| Interest Receivable | ||||||||||||
| Pre-Tax Profit | ||||||||||||
| Tax | ||||||||||||
| Profit After Tax | ||||||||||||
| Dividends Paid | ||||||||||||
| Retained Profit | ||||||||||||
| Employee Costs | ||||||||||||
| Number Of Employees | 1 | 1 | ||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 2 | 1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 9,992 | 11,781 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 9,992 | 11,781 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total assets | 9,992 | 11,783 | 1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 3,529 | 2,238 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 3,529 | 2,238 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 720 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 720 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 4,249 | 2,238 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 5,743 | 9,545 | 1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total shareholders funds | 5,743 | 9,545 | 1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | ||||||||||||
| Depreciation | 0 | 0 | 0 | |||||||||
| Amortisation | 0 | 0 | 0 | |||||||||
| Tax | ||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -1,789 | 11,781 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 1,291 | 2,238 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 720 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | 0 | -1,000 | 0 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||
| interest | ||||||||||||
| cash flow from financing | ||||||||||||
| cash and cash equivalents | ||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
transblood limited Credit Report and Business Information
Transblood Limited Competitor Analysis
Perform a competitor analysis for transblood limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in WD6 area or any other competitors across 12 key performance metrics.
transblood limited Ownership
TRANSBLOOD LIMITED group structure
Transblood Limited has no subsidiary companies.
Ultimate parent company
TRANSBLOOD LIMITED
07493663
transblood limited directors
Transblood Limited currently has 1 director, Mr Jan Majkowski serving since Jan 2011.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Jan Majkowski | England | 45 years | Jan 2011 | - | Director |
P&L
January 2023turnover
33.5k
-1%
operating profit
-3.8k
0%
gross margin
27.5%
+0.28%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2023net assets
5.7k
-0.4%
total assets
10k
-0.15%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
transblood limited company details
company number
07493663
Type
Private limited with Share Capital
industry
70229 - Management consultancy activities (other than financial management)
86900 - Other human health activities
86220 - Specialist medical practice activities
incorporation date
January 2011
age
13
incorporated
UK
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
last accounts submitted
January 2023
address
2 ark avenue, borehamwood, hertfordshire, WD6 1GH
accountant
-
auditor
-
transblood limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to transblood limited.
transblood limited Companies House Filings - See Documents
| date | description | view/download |
|---|
